Search for Clinical Trial Results
Lymphomatoid Granulomatosis - 25 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas Condition:
|
Completed |
Study Name: RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors Condition:
|
Completed |
Study Name: Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Condition:
|
Completed |
Study Name: FAU in Treating Patients With Advanced Solid Tumors or Lymphoma Condition:
|
Completed |
Study Name: Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction Condition:
|
Completed |
Study Name: PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas Condition:
|
Terminated |
Study Name: SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma Condition: Date: 2024-05-13 |
Completed |
Study Name: MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas Condition:
|
Terminated |
Study Name: Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas Condition:
|
Terminated |
Study Name: MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma Condition:
|